ELI LILLY DANMARK A/S

Business activities and missionEli Lilly and Company discovers, develops, manufactures, and markets products in the business segment of humanpharmaceuticals. Our purpose is to unite caring with discovery to create medicines that make life better for peoplearound the world. Most of the products we sell today were discovered or developed by our own scientists, and ourlong-term success depends on our ability to continually discover or acquire, develop, and commercialize innovativenew medicines. Our products are sold in approximately 90 countries, and globally Lilly medicines helped 71 millionpeople manage serious and challenging illnesses last year, including diabetes, obesity, cancer, and autoimmuneconditions. The activities of Eli Lilly Danmark A/S include the prioritized therapeutic areas Cardiometabolic Health, Oncology, Immunology and Neuroscience in Denmark, Finland, Norway, and Iceland.